FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting

June 28, 2022

At a previous Vaccines and Related Biological Products Advisory (VRBPAC) meeting on April 6, 2022, the committee discussed considerations that should inform strain composition decisions to ensure that available COVID-19 vaccines continue to meet public health needs, when and how frequently to consider strain composition changes, and the process that should be used for making a recommendation for updating the vaccine strain composition.

As a follow-up to the April 6th VRBPAC discussion, this June 28th, 2022 VRBPAC meeting is being held to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified.

Latest articles

Major Cleveland Clinic study finds −26.9% effectiveness for influenza vaccine during the...
Is The Human Body Designed ‘To Last Hundreds Of Years’ And What...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!